Cite
HARVARD Citation
Weigand, K. et al. (2022). Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol‐associated disease etiology. European journal of immunology. 52 (4), pp. 633-645. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Weigand, K. et al. (2022). Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol‐associated disease etiology. European journal of immunology. 52 (4), pp. 633-645. [Online].